News
A PHARMACY worker who stole weight loss drug Ozempic and sold it on the black market was spared jail yesterday. Akshay Sennik ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.
Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...
A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...
DR NELLY KAMWALEKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 diabetes and obesity. Two drugs, Semaglutide and Tirzepatide ...
At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
GLP-1 receptor agonist drugs like Ozempic help people manage type 2 diabetes. Foods like Greek yogurt and avocados can't do ...
Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results